Aprea Therapeutics Inc. (APRE)
2.05
-0.04 (-1.91%)
At close: Mar 31, 2025, 3:59 PM
2.05
0.00%
After-hours: Mar 31, 2025, 07:32 PM EDT
Aprea Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 22.85M | 21.61M | 28.79M | 53.08M | 89.02M | 130.09M | 65.68M | 24.4M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 40.72K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 321.83K | n/a | n/a | n/a | n/a | n/a | 111.00 | 121.00 |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 726.25K | 914.27K | 1.37M | 7.02M | 6.8M | 5.91M | 322.15K | 329.86K |
| Total Current Assets | 23.58M | 22.52M | 30.15M | 56.58M | 92.42M | 133.04M | 66M | 24.73M |
| Property-Plant & Equipment | 81.52K | 88.36K | 2.32K | 239.05K | 388.51K | 563.14K | 24.45K | 30.34K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 403.35K | 129.08K | 2.32K | 239.05K | 388.51K | 563.14K | 24.56K | 30.46K |
| Total Assets | 23.98M | 22.65M | 30.16M | 56.82M | 92.81M | 133.61M | 66.02M | 24.76M |
| Account Payables | 1.35M | 1.67M | 842.75K | 1.77M | 4.5M | 2.18M | 1.74M | 1.66M |
| Deferred Revenue | n/a | 528.97K | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | 380.94K | 512.62K | 484.66K | n/a | n/a |
| Other Current Liabilities | 2.01M | 2.19M | 2.36M | 5.16M | 10.31M | 6.4M | 3.13M | 2.64M |
| Total Current Liabilities | 3.36M | 4.39M | 3.2M | 7.32M | 15.33M | 9.06M | 4.87M | 4.3M |
| Long-Term Debt | n/a | n/a | n/a | n/a | 78.85K | 302.62K | n/a | n/a |
| Other Long-Term Liabilities | 1.31M | 1.31M | 1.31M | n/a | n/a | n/a | 112.59M | 56.23M |
| Total Long-Term Liabilities | 1.31M | 1.31M | 1.31M | n/a | 78.85K | 302.62K | 112.59M | 56.23M |
| Total Liabilities | 4.67M | 5.7M | 4.51M | 7.32M | 15.41M | 9.36M | 117.46M | 60.53M |
| Total Debt | n/a | n/a | n/a | 190.47K | 335.16K | 544.95K | n/a | n/a |
| Common Stock | 5.48K | 3.74K | 2.65K | 21.86K | 21.19K | 21.02K | 127.09K | 126.84K |
| Retained Earnings | -321.04M | -308.08M | -293.8M | -181.13M | -144.01M | -90.53M | -62.47M | -46.94M |
| Comprehensive Income | -10.63M | -10.61M | -10.62M | -10.36M | -10.04M | -11.53M | -8.76M | -8.29M |
| Shareholders Equity | 19.31M | 18.26M | 25.64M | 49.51M | 77.4M | 124.24M | -51.44M | -35.77M |
| Total Investments | n/a | 40.72K | n/a | n/a | n/a | n/a | n/a | n/a |